TLR7 and chronic obstructive pulmonary disease: Our study provides new insights and possible mechanisms of how TLR7 potentiates tissue-specific responses through mast cells, and shows that prophylactic and therapeutic targeting of TLR7 reduced lung mast cell numbers, emphysema and experimental COPD.